Potassium cardioprotective in people with an ICD

Key takeaways:

Increasing serum potassium reduced risk for adverse outcomes in patients with an ICD.

Increased potassium and reduced sodium intake may benefit heart health in the overall population.

Increased potassium intake and dietary guidance reduced risk for adverse events in patients with an implantable cardioverter defibrillator and may be an affordable intervention to reduce overall CV risk.

Results of the multicenter, open-label, randomized superiority POTCAST trial were presented at the European Society of Cardiology Congress and simultaneously published in T he New England J ournal of Medicine .

Data were derived from Jøns C, et al. Hot line 1. Presented at: European Society of Cardiology Congress; Aug. 29-Sept. 1, 2025; Madrid (hybrid meeting).

“The human body e